Delivery Order SPE2DB20D1100-SPE2DB25FC9N9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,797.51 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen injectors. This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $40,155.43 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside transaction executed on September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with extensive experience...
- The Defense Logistics Agency awarded a $54,511.48 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This competitive award, issued without set-aside designation, utilizes a firm fixed-price delivery order structure under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $59,150 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 28, 2025. This non-set-aside competitive award was issued on August 27, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order under a larger indefinite delivery contract vehicle, this award represents a tactical pharmaceutical...
- The Defense Logistics Agency awarded a $127,949.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen injectors, with a completion date of September 19, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $38,911.60 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This firm fixed price, non-set-aside contract will be completed by August 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $28,786.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of July 15, 2025. This non-set-aside delivery order represents a competitive award to the pharmaceutical distributor, which is headquartered in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $64,305.29 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/mL pen injectors. This firm fixed-price delivery order, awarded September 5, 2025, with completion targeted for September 8, 2025, will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a delivery order valued at approximately $77.4K to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injections, with a completion deadline of September 30, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor supporting federal medical procurement requirements. The delivery order will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, utilizing...
- The Defense Logistics Agency awarded a $27,869.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors. This competitive award, issued on April 25, 2025, with an ultimate completion date of April 28, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. SKYRIZI is a biologic medication used to treat inflammatory skin conditions, and this delivery order fulfills federal medical supply...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC9N9Delivery Order
The Defense Logistics Agency awarded a $16,496.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of June 18, 2025. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's comprehensive prime vendor agreement with DLA, which supplies critical medical commodities including specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs. SKYRIZI, a biologic dermatological treatment, falls within the specialized pharmaceutical portfolio the contractor regularly provides to the Defense Health Agency and other federal healthcare systems. The delivery order demonstrates AmerisourceBergen's established capacity to fulfill federal medical supply requirements through open competition and the flexibility of the underlying IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 6/17/25 |